Lipid Mediators |
EPA Derived |
RvE1 |
Macrophages (human and murine) |
-Increases phagocytosis of Zymosan, E. coli, C. albicans
|
(15–19) |
Neutrophils (human and murine) |
-Promotes efferocytosis of apoptotic PMN |
|
RvE2 |
Macrophages (human) |
-Increases phagocytosis of Zymosan |
(20) |
|
RvE4 |
Macrophages (human) |
-Increases efferocytosis of apoptotic PMN, effete RBCs |
(21, 22) |
DHA Derived |
RvD1, AT-RvD1 |
Macrophages (human, murine, rat) |
- Increases phagocytosis of Zymosan, E. coli, P. aeruginosa, NTHi, IgA-OVA-coated beads, Amyloidβ, clot particles, cancer cell debris |
(23–41) |
Neutrophils (human and murine) |
- Promotes efferocytosis of apoptotic PMN, osteoblasts, Jurkats, macrophages, thymocytes, and sickle cell RBCs |
|
Fibroblasts (human) |
-Enhances clearance of necroptotic cells |
|
RvD2 |
Macrophages (human and murine) |
-Enhances phagocytosis of live E. coli
|
(29, 42–44) |
Neutrophils (human and murine) |
|
-Promotes efferocytosis of apoptotic PMN apoptotic osteoblasts |
|
RvD3, AT-RvD3 |
Macrophages (human and murine) |
-Enhances phagocytosis |
(40, 45) |
-Promotes efferocytosis of apoptotic PMN |
|
|
-Increases uptake of cancer cell debris |
|
RvD4 |
Macrophages (human) |
-Enhances phagocytosis of S. aureus, Zymosan
|
(25, 46) |
Fibroblasts (Human) |
Whole blood phagocytes |
-Increases efferocytosis of apoptotic PMN |
|
RvD5 |
Macrophages (human) |
-Enhances phagocytosis of E. coli
|
(23) |
MaR1, MaR2 |
Macrophages (human and murine) |
-Enhances phagocytosis of E. coli, Zymosan |
(47–50) |
–Increases efferocytosis of apoptotic PMN |
PD1/NPD1, AT-PD1 |
Macrophages (human and murine) |
-Increases efferocytosis of apoptotic PMN, thymocytes |
(15, 23, 41, 51–54) |
Cys SPMs: |
Macrophages (human and murine) |
-Enhances phagocytosis of E. coli, Zymosan |
(8, 55–59) |
MCTR1, |
MCTR2, |
MCTR3, |
-Increases efferocytosis of apoptotic PMN |
PCTR1, |
PCTR2, |
PCTR3, |
RCTR1, |
RCTR2, |
RCTR3 |
n-3 DPA derived SPMs |
RvD5n-3DPA |
Macrophages (human and murine) |
-Increases phagocytosis of S. aureus, Zymosan |
(9, 14, 60) |
PD1n-3DPA |
Marn-3DPA |
RvDn-3DPA |
RvT |
-Enhances efferocytosis of apoptotic HL-60 cells |
AA Derived |
LXA4, AT-LXA4
|
Macrophages (human, murine, rat, THP-1 cells) |
-Enhances efferocytosis of apoptotic PMN |
(61–63) |
LXB4, AT-LXB4
|
Macrophages (human, murine, rat) |
-Increases phagocytosis of E. coli
|
(63, 64) |
-Enhances efferocytosis of apoptotic PMN |
Proteins
|
|
Annexin A1, Ac2-26 |
Macrophages (human) |
-Enhances efferocytosis of apoptotic PMN |
(65) |
DEL-1 |
Macrophages (murine) |
-Increases efferocytosis of apoptotic PMN |
(66) |
IL-10 |
Macrophages (human) |
-Increases phagocytosis of E. coli
|
(67) |
-Enhances efferocytosis of apoptotic PMN |
IFN-β |
Macrophages (murine) |
-Enhances efferocytosis of apoptotic PMN |
(68) |
|
|
Galectin-1 |
Microglial cells Macrophages |
-Enhances phagocytosis of myelin |
(69, 70) |
–Increases efferocytosis of apoptotic PMN |
|
|
Galectin-3 |
Neutrophils (human) |
-Enhances phagocytosis IgG-RBCs |
(71, 72) |
Macrophages (murine) |
–Increases efferocytosis of apoptotic PMN |
|
|
Melanocortin |
Macrophages (murine) |
-Enhances phagocytosis of zymosan |
(73) |
–Increases efferocytosis of apoptotic PMN |
|
|
Alpha-2-macroglobin |
Macrophages (murine) |
-Enhances phagocytosis of zymosan |
(74) |
–Increases efferocytosis of apoptotic PMN |
Gases
|
|
H2S |
Macrophages |
-Enhances phagocytosis of bacteria |
(75) |
CO |
Macrophages (human) |
-Increases phagocytosis of zymosan |
(76) |
–Increases efferocytosis of apoptotic PMN |
Nucleotides
|
|
Adenosine |
PMN |
-Stimulates Fc-mediated phagocytosis |
(77) |
Lipids
|
|
Estrogen |
Microglial cells |
-Stimulated efferocytosis of apoptotic PC12 cells |
(78) |